Cargando…
Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials
Reperfusion therapy is the most crucial strategy for rescuing ischemic myocardium and reducing infarction size. Cyclosporine A (CsA) can protect against reperfusion-induced myocardial necrosis. However, the clinical effects of CsA on myocardial infarction (MI) remain uncertain. This study investigat...
Autores principales: | Yingzhong, Chen, lin, Cai, Chunbin, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949180/ https://www.ncbi.nlm.nih.gov/pubmed/27478734 http://dx.doi.org/10.1186/s40064-016-2751-y |
Ejemplares similares
-
Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials
por: Song, Kangxing, et al.
Publicado: (2015) -
Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury
por: Hefler, Joshua, et al.
Publicado: (2022) -
Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs
por: Skyschally, Andreas, et al.
Publicado: (2010) -
Reperfusion injury in acute myocardial infarction
por: Simonis, Gregor, et al.
Publicado: (2012) -
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)